Dry Needling for Shoulder Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Shoulder Pain+1 MoreDry Needling - Other
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

Shoulder pain is one of the most common reasons people consult with their primary health care provider, and 40-50% of these patients with shoulder pain continued to complain of persistent symptoms after 6 to 12 months. It has been suggested that the presence of myofascial trigger points (MTrPs) may contribute to the chronicity of shoulder symptoms. An MTrP is a hyperirritable taut band of tissue within a muscle that produces pain when stimulated MTrPs are common in patients with shoulder disorders and occur most often in the infraspinatus muscle of a painful shoulder MTrPs were associated with an acidic biochemical environment with elevated levels of inflammatory mediators, neuropeptides, and proinflammatory cytokines such as bradykinin and calcitonin g-related peptide. It was hypothesized that metabolic demands on muscle and capillary constrictions may contribute to the development of MTrPs. To date, only a few studies have examined the vascular environment of MTrPs and surrounding areas before and after dry needling. No studies have yet examined whether dry needling would change blood flow in patients with shoulder pathology. Therefore, the purpose of this pilot study is to examine the effect of dry needling on blood flow of the infraspinatus muscle using color Doppler imaging in individuals with shoulder pain. The secondary purpose is to examine the effect of DN on shoulder motion and sensitivity to pressure in individuals with shoulder pain.

Eligible Conditions
  • Shoulder Pain
  • Dry Needling

Treatment Effectiveness

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Change from baseline EDV immediately

Change from baseline EDV immediately
End Diastolic Velocity (EDV)
Change from baseline PI immediately
Pulsatile Index (PI)
Change from baseline PPT immediately
Pain Pressure Thresholds (PPT)
Change from baseline PSV immediately
Peak Systolic Velocity
Change from baseline RI immediately
Resistive Index (RI)
Change from baseline shoulder range of motion immediately
Shoulder Range of Motion

Trial Safety

Trial Design

2 Treatment Groups

Dry Needling
1 of 2
Sham Dry Needling
1 of 2

Experimental Treatment

Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Dry Needling · Has Placebo Group · N/A

Dry Needling
Other
Experimental Group · 1 Intervention: Dry Needling · Intervention Types: Other
Sham Dry Needling
Other
PlaceboComparator Group · 1 Intervention: Sham Dry Needling · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline edv immediately

Who is running the clinical trial?

Texas Woman's UniversityLead Sponsor
78 Previous Clinical Trials
5,357 Total Patients Enrolled
3 Trials studying Shoulder Pain
174 Patients Enrolled for Shoulder Pain
Jace A Brown, DPTPrincipal InvestigatorTexas Woman's University

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have at least one MTrP with referral pain pattern in the infraspinatus muscle.
References